PublicationsDiatech Admin2018-12-12T10:54:12+01:00

Publications

Leader in the development, production and
commercialisation of pharmacogenetics tests
for cancer precision medicine.

603, 2023

Andrea Cardia et al., Identification of MGMT Downregulation Induced by miRNA in Glioblastoma and Possible Effect on Temozolomide Sensitivity

2002, 2023

Andrea Ronchi et al., To get the most out of the least: BRAF molecular evaluation in melanoma metastases on cell suspension from fine needle aspiration cytology (FNAC) needle rinses

1002, 2023

Federica Zannier et al., Impact of DNA mismatch repair proteins deficiency on number and ratio of lymph nodal metastases in colorectal adenocarcinoma

3011, 2022

Antonello Cardoni et al., A Pediatric Case of High-Grade Secretory Carcinoma of the Maxillary Sinus With ETV6::NTRK3 Gene Fusion, Therapeutic Implications, and Review of the Literature

2911, 2022

Anello Marcello Poma et al., Transcriptional changes of tissue-specific genes in multiple endocrine organs: a study of lethal COVID-19 cases

2111, 2022

Jonathan E Thompson, Matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in veterinary medicine: Recent advances (2019-present).

1011, 2022

Beatrice Stefanelli et al., Concomitant Administration of Capecitabine and Folate Supplements: Need to Encourage Medication Reconciliation

311, 2022

Elisa Dal Cin et al., HPV impact on oropharyngeal cancer radiological staging: 7th vs 8th edition of AJCC TNM classification.

2510, 2022

Andromachi Kotsafti et al., Tumor immune microenvironment in therapy-naive esophageal adenocarcinoma could predict the nodal status

1310, 2022

Clotilde Sparano et al., Classic and follicular variant of papillary thyroid microcarcinoma: two different phenotypes beyond tumour size

3009, 2022

Mariam M Al-Omari et al., Review of current in vitro COVID-19 diagnostics methods

2809, 2022

Silvia Chiesa et al., Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma

Previous 8910 Next